Oxamate Attenuates Glycolysis and ER Stress in Silicotic Mice
Glycolysis and ER stress have been considered important drivers of pulmonary fibrosis. However, it is not clear whether glycolysis and ER stress are interconnected and if those interconnections regulate the development of pulmonary fibrosis. Our previous studies found that the expression of LDHA, a key enzyme involved in glycolysis, was increased in silica-induced macrophages and silicotic models, and it was closely related to silicosis fibrosis by participating in inflammatory response. However, whether pharmacological inhibition of LDHA is beneficial to the amelioration of silicosis fibrosis remains unclear. In this study, we investigated the effects of oxamate, a potent inhibitor of LDHA, on the regulation of glycolysis and ER stress in alveolar macrophages and silicotic mice. We found that silica induced the upregulation of glycolysis and the expression of key enzymes directly involved in ER stress in NR8383 macrophages. However, treatment of the macrophages and silicotic mice with oxamate attenuated glycolysis and ER stress by inhibiting LDHA, causing a decrease in the production of lactate. Therefore, oxamate demonstrated an anti-fibrotic role by reducing glycolysis and ER stress in silicotic mice.
Топ-30
Журналы
|
1
2
|
|
|
International Journal of Molecular Sciences
2 публикации, 13.33%
|
|
|
Respiratory Research
2 публикации, 13.33%
|
|
|
Frontiers in Pharmacology
1 публикация, 6.67%
|
|
|
Neuroglia
1 публикация, 6.67%
|
|
|
Pain
1 публикация, 6.67%
|
|
|
Frontiers in Endocrinology
1 публикация, 6.67%
|
|
|
Clinical and Experimental Hypertension
1 публикация, 6.67%
|
|
|
Journal of Hazardous Materials
1 публикация, 6.67%
|
|
|
Toxicology
1 публикация, 6.67%
|
|
|
Advances in Clinical Medicine
1 публикация, 6.67%
|
|
|
Cellular and Molecular Immunology
1 публикация, 6.67%
|
|
|
Cell Death and Disease
1 публикация, 6.67%
|
|
|
ACS Nano Medicine
1 публикация, 6.67%
|
|
|
1
2
|
Издатели
|
1
2
3
4
|
|
|
Springer Nature
4 публикации, 26.67%
|
|
|
MDPI
3 публикации, 20%
|
|
|
Frontiers Media S.A.
2 публикации, 13.33%
|
|
|
Elsevier
2 публикации, 13.33%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 публикация, 6.67%
|
|
|
Taylor & Francis
1 публикация, 6.67%
|
|
|
Hans Publishers
1 публикация, 6.67%
|
|
|
American Chemical Society (ACS)
1 публикация, 6.67%
|
|
|
1
2
3
4
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.